Ramosetron

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ramosetron
Ramosetron.svg
Systematic (IUPAC) name
(1-methyl-1H-indol-3-yl)[(5R)-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]methanone
Clinical data
AHFS/Drugs.com International Drug Names
Legal status ?
Routes Intravenous
Pharmacokinetic data
Half-life 5.8 hours
Identifiers
CAS number 132907-72-3 YesY
ATC code None
PubChem CID 108000
IUPHAR ligand 2301
ChemSpider 97112 N
UNII 7ZRO0SC54Y N
ChEMBL CHEMBL1643895 N
Chemical data
Formula C17H17N3O 
Mol. mass 279.33 g/mol
 N (what is this?)  (verify)

Ramosetron (INN) is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting.[1] Ramosetron is also indicated for a treatment of “diarrhea-predominant irritable bowel syndrome in males”.[2] In India it is marketed under the brand name of "IBset".


It is only licensed for use in Japan and selected Southeast Asian countries. In Japan it is sold under the tradename Iribo (イリボー). [3] Elsewhere it is commonly sold under the tradename Nasea and in India as Nozia (300 mcg/ml Inj. & 100 mcg Tab.) [4]

References[edit]